Literature DB >> 26099644

Prognostic significance of arterial and venous thrombosis in resected specimens for non-small cell lung cancer.

Whenhui Chen1, Yuhui Zhang1, Yuanhua Yang1, Zhenguo Zhai1, Chen Wang2.   

Abstract

BACKGROUND: Venous thromboembolism(VTE) is common after pneumonectomy for malignancy and predicts poor survival. Routine screening for VTE with noninvasive tests has low sensitivity and specificity. Biopsy of lung has a place in establishing the nature and severity of the vascular alterations. In this study, we investigated the incidence, clinical and pathological characteristics of thrombosis in excised specimens after pneumonectomy, and its association with survival rate in patients with non-small cell lung cancer (NSCLC).
METHODS: The studied population consisted 94 consecutive patients after pneumonectomy for NSCLC in Beijing Chao-Yang Hospital, The excised tissue specimens were stained by haematoxylin & eosin staining (HE) to observe thrombosis events. All the patients were followed up for 2years. The survival data was analyzed by Kaplan-Meier analysis.
RESULTS: Overall thrombosis events occurred in 56 (59.6%) of 94 NSCLC cases, pulmonary arterial thrombosis was found in 24 cases, and pulmonary venous thrombosis was found in 32 cases. Furthermore, 30 of 56 cases with thrombosis were accompanied by tumor emboli or tumor vascular infiltrating. Thrombosis risk was associated with cancer grade (P=0.005). Kaplan-Meier analysis showed that patients with thrombosis had lower survival rate than those without thrombosis (P=0.025).
CONCLUSIONS: The incidence of thrombosis in excised tissue after pneumonectomy was high in patients with NSCLC, and it may be a marker of poor outcome.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  lung neoplasias; prognosis; thrombosis

Mesh:

Year:  2015        PMID: 26099644     DOI: 10.1016/j.thromres.2015.06.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.

Authors:  Harry E Fuentes; D M Oramas; L H Paz; Y Wang; X A Andrade; A J Tafur
Journal:  J Gastrointest Cancer       Date:  2018-12

2.  Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer.

Authors:  Ruishuang Ma; Yayan Bi; Junjie Kou; Jin Zhou; Jialan Shi
Journal:  Cancer Biol Ther       Date:  2017-07-18       Impact factor: 4.742

Review 3.  The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery.

Authors:  Hui Li; Gening Jiang; Servet Bölükbas; Chun Chen; Haiquan Chen; Keneng Chen; Jun Chen; Xiangli Cui; Wentao Fang; Shugeng Gao; Sebastien Gilbert; Jianhua Fu; Xiangning Fu; Yasuhiro Hida; Shanqing Li; Xiaofei Li; Yin Li; Hecheng Li; Yongjun Li; Deruo Liu; Lunxu Liu; Jianxing He; Jie He; Giuseppe Marulli; Hiroyuki Oizumi; Marc de Perrot; René Horsleben Petersen; Yaron Shargall; Alan Sihoe; Qunyou Tan; Qun Wang; Shun Xu; Mei Yang; Yuanhua Yang; Zhentao Yu; Lanjun Zhang; Xun Zhang; Heng Zhao; Xiuyi Zhi
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

4.  Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma.

Authors:  Yuchen Wang; B M Attar; K Hinami; H E Fuentes; P Jaiswal; H Zhang; C S Simons-Linares; A J Tafur
Journal:  J Gastrointest Cancer       Date:  2018-09

Review 5.  Cancer and Thrombosis: The Platelet Perspective.

Authors:  Claire K S Meikle; Clare A Kelly; Priyanka Garg; Leah M Wuescher; Ramadan A Ali; Randall G Worth
Journal:  Front Cell Dev Biol       Date:  2017-01-05

6.  Prognostic Values of Platelet-Associated Indicators in Resectable Lung Cancers.

Authors:  Jing-Jing Wang; Yin-Ling Wang; Xin-Xin Ge; Meng-Dan Xu; Kai Chen; Meng-Yao Wu; Fei-Ran Gong; Min Tao; Wen-Jie Wang; Liu-Mei Shou; Wei Li
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

7.  Risk Factors for Gastric Cancer-Associated Thrombotic Diseases in a Han Chinese Population.

Authors:  Bo Song; Yamei Wang; Xiuzhi Zhu; Li Zhang; Hui Zhou; Hongmei Zhang; Tianliang Zhang; Wansheng Ji
Journal:  Biomed Res Int       Date:  2021-05-21       Impact factor: 3.411

8.  The association between pulmonary embolism and the cancer-related genomic alterations in patients with NSCLC.

Authors:  Wei Xiong; He Du; Wei Ding; Jinyuan Sun; Mei Xu; Xuejun Guo
Journal:  Respir Res       Date:  2020-07-16

9.  Platelet-T cell aggregates in lung cancer patients: Implications for thrombosis.

Authors:  Claire K Meikle; Adam J Meisler; Cara M Bird; Joseph A Jeffries; Nabila Azeem; Priyanka Garg; Erin L Crawford; Clare A Kelly; Tess Z Gao; Leah M Wuescher; James C Willey; Randall G Worth
Journal:  PLoS One       Date:  2020-08-10       Impact factor: 3.240

10.  [Perioperative Venous Thromboembolism (VTE) Prophalaxis 
in Thoracic Cancer Patients: Chinese Experts Consensus].

Authors:  Hui Li; Gening Jiang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.